Market Tracker

06/23 5:16pm ET

Redhill Biopharma Ltd (NASDAQ:RDHL)

9.08
Delayed Data
As of Jun 23
 +0.12 / +1.34%
Today’s Change
8.40
Today|||52-Week Range
16.54
-13.19%
Year-to-Date
No recent news for Redhill Biopharma Ltd.

Today’s Trading

Previous close8.96
Today’s open8.96
Day’s range8.70 - 9.09
Volume53,288
Average volume (3 months)65,544
Market cap$155.8M
Dividend yield--
Data as of 3:59pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-21.48%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+3,278.54%
P/E ratio--
Price/Sales1,329.82
Price/Book2.39

Competitors

 Today’s
change
Today’s
% change
CURRCure Pharmaceutical ...+0.10+1.52%
VRNAVerona Pharma PLC+0.52+4.51%
OCXOncoCyte Corp+0.05+0.93%
MDWDMediwound Ltd-0.57-7.37%
Data as of 4:01pm ET, 06/23/2017

Financials

Next reporting dateJuly 26, 2017
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$101.3K
Annual profit (last year)-$29.5M
Net profit margin-29,079.21%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Dror Ben-Asher
Chief Operating Officer
Gilead Raday
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts